Literature DB >> 22566228

Neutralization of heparin activity.

Menaka Pai1, Mark A Crowther.   

Abstract

Heparin is the mainstay in the treatment and prevention of thrombosis in such diverse clinical settings as venous thromboembolism, acute coronary syndrome, cardiopulmonary bypass, and hemodialysis. However, the major complication of heparin - like that of all anticoagulants - is bleeding. Heparin may need to be reversed in the following settings: clinically significant bleeding; prior to an invasive procedure; at the conclusion of a procedure involving extracorporeal circulation (e.g., cardiopulmonary bypass, dialysis). This chapter discusses protamine sulfate, as well as several other agents that are able to neutralize heparin, including their pharmacological properties, indications, dosing, and efficacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566228     DOI: 10.1007/978-3-642-23056-1_11

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  7 in total

1.  Structural characterization of a clinically described heparin-like substance in plasma causing bleeding.

Authors:  Yanlei Yu; Karen Bruzdoski; Vadim Kostousov; Lisa Hensch; Shiu-Ki Hui; Fakiha Siddiqui; Amber Farooqui; Ahmed Kouta; Fuming Zhang; Jawed Fareed; Jun Teruya; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2020-05-19       Impact factor: 9.381

Review 2.  Balloon Occlusion Types in the Treatment of Coronary Perforation during Percutaneous Coronary Intervention.

Authors:  Xiangfei Wang; Junbo Ge
Journal:  Cardiol Res Pract       Date:  2014-11-20       Impact factor: 1.866

3.  Polybrene induces neural degeneration by bidirectional Ca2+ influx-dependent mitochondrial and ER-mitochondrial dynamics.

Authors:  Feixiang Bao; Hongyan Shi; Mi Gao; Liang Yang; Lingyan Zhou; Qiuge Zhao; Yi Wu; Keshi Chen; Ge Xiang; Qi Long; Jingyi Guo; Jian Zhang; Xingguo Liu
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

Review 4.  Cationic Nanomaterials for Autoimmune Diseases Therapy.

Authors:  Baozhao Xie; Keqian Du; Fujian Huang; Zhiming Lin; Linping Wu
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

5.  Nursing Observation of Improved Administration Route of Protamine Sulfate Neutralizing Heparin.

Authors:  Jia Hu; Suiting Zeng; Ziqi Wang; Qiuping Chen; Ya Shi; Yuanzhou Wu
Journal:  J Healthc Eng       Date:  2022-03-08       Impact factor: 2.682

6.  miR-3064-5p and miR-4745-5p affect heparin sensitivity in patients undergoing cardiac surgery by regulating AT-III and factor X mRNA levels.

Authors:  Hai-Ping Ma; Min Fu; Maisitanguli Masula; Chang-Shuang Xing; Qiang Zhou; Jing-Tong Tan; Jiang Wang
Journal:  Front Physiol       Date:  2022-08-12       Impact factor: 4.755

7.  Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate.

Authors:  John Hogwood; Barbara Mulloy; Elaine Gray
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.